Back
Polaris Inc. 10K Form
Sell
32
PII
Polaris Inc.
Last Price:
$65.74
Seasonality Move:
0.79%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-23 | 10Q | PII/Polaris Inc. Quarterly |
| 2023-10-24 | 10Q | PII/Polaris Inc. Quarterly |
| 2023-07-25 | 10Q | PII/Polaris Inc. Quarterly |
| 2023-04-25 | 10Q | PII/Polaris Inc. Quarterly |
| 2022-10-25 | 10Q | PII/Polaris Inc. Quarterly |
| 2022-07-26 | 10Q | PII/Polaris Inc. Quarterly |
Receive PII News And Ratings
See the #1 stock for the next 7 days that we like better than PII
PII Financial Statistics
Sales & Book Value
| Annual Sales: | $7.2B |
|---|---|
| Cash Flow: | $116.7M |
| Price / Cash Flow: | 5.75 |
| Annual Sales: | $20.45 |
| Price / Book: | 3.22 |
Profitability
| EPS (TTM): | -2.65560 |
|---|---|
| Net Income (TTM): | $-150.7M |
| Gross Margin: | $1.4B |
| Return on Equity: | -12.13% |
| Return on Assets: | -2.76% |
Polaris Inc. Earnings Forecast
Key Polaris Inc. Financial Ratios
-
The Gross Profit Margin over the past 38 years for PII is 19.57%.
-
The Selling, General & Administrative Expenses for PII have been equal to 13.06% of Gross Profit Margin.
-
The Research & Development expenses have been 4.70% of Revenue.
-
The Interest Expense is 127.97% of Operating Income.
-
The Net Earning history of PII is 1.55% of Total Revenues.
-
Per Share Earnings over the last 38 years have been positive in 23 years.
Polaris Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Leisure Products |
| Sector: | Consumer Discretionary |
| Current Symbol: | PII |
| CUSIP: | 731068 |
| Website: | polaris.com |
Debt
| Debt-to-Equity Ratio: | 1.61 |
|---|---|
| Current Ratio: | 1.02 |
| Quick Ratio: | 0.22 |
Price-to-Earnings
| Trailing P/E Ratio: | 33.69 |
|---|---|
| Forward P/E Ratio: | 38.87 |
PII Technical Analysis vs Fundamental Analysis
Sell
32
Polaris Inc. (PII)
is a Sell
Is Polaris Inc. a Buy or a Sell?
-
Polaris Inc. stock is rated a SellThe current Polaris Inc. [PII] share price is $65.72. The Score for PII is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.